We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
+6.2%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$9.56B
AUM Growth
+$531M
Cap. Flow
+$49.6M
Cap. Flow %
0.52%
Top 10 Hldgs %
14.04%
Holding
1,755
New
15
Increased
420
Reduced
1,119
Closed
198

Top Sells

Rank Stock Value
1
DOC icon
Healthpeak Properties
DOC
+$48.2M
2
CLC
Clarcor
CLC
+$15.4M
3
AMGN icon
Amgen
AMGN
+$11.3M
4
AAPL icon
Apple
AAPL
+$9.79M
5
NUE icon
Nucor
NUE
+$8.91M

Sector Composition

Rank Sector Weight
1 Financials 15.52%
2 Healthcare 14.53%
3 Technology 12.08%
4 Consumer Staples 11.47%
5 Industrials 10.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GERN icon
1376
Geron
GERN
$924M
$232K ﹤0.01%
102,321
-27,070
-21% -$57.7K
HL icon
1377
Hecla Mining
HL
$10.1B
$232K ﹤0.01%
43,943
-17,375
-28% -$100K
WERN icon
1378
Werner Enterprises
WERN
$2.57B
$232K ﹤0.01%
8,849
-2,622
-23% -$71.5K
ABCO
1379
DELISTED
Advisory Board Co
ABCO
$232K ﹤0.01%
4,948
-1,837
-27% -$81.1K
ADEA icon
1380
Adeia
ADEA
$2.88B
$231K ﹤0.01%
25,746
-8,248
-24% -$88.7K
IMAX icon
1381
IMAX
IMAX
$2.37B
$231K ﹤0.01%
6,782
-2,683
-28% -$87.5K
MEI icon
1382
Methode Electronics
MEI
$555M
$231K ﹤0.01%
5,055
-1,626
-24% -$69.3K
SPOK icon
1383
Spok Holdings
SPOK
$223M
$231K ﹤0.01%
12,166
-4,360
-26% -$84.6K
OTIC
1384
DELISTED
Otonomy, Inc.
OTIC
$231K ﹤0.01%
18,882
-4,926
-21% -$71.7K
ARNA
1385
DELISTED
Arena Pharmaceuticals Inc
ARNA
$231K ﹤0.01%
15,809
-4,204
-21% -$62.3K
EVER
1386
DELISTED
Everbank Financial Corp
EVER
$231K ﹤0.01%
11,859
-4,687
-28% -$91.1K
HMN icon
1387
Horace Mann Educators
HMN
$2.1B
$230K ﹤0.01%
5,606
-1,801
-24% -$75.5K
WEN icon
1388
Wendy's
WEN
$1.34B
$230K ﹤0.01%
16,891
-3,895
-19% -$53.1K
HUBG icon
1389
HUB Group
HUBG
$3.04B
$229K ﹤0.01%
9,872
-2,952
-23% -$69.8K
IQV icon
1390
IQVIA
IQV
$34.9B
$229K ﹤0.01%
+2,849
New +$222K
AAT
1391
American Assets Trust
AAT
$1.49B
$228K ﹤0.01%
5,455
-1,722
-24% -$73.8K
GPI icon
1392
Group 1 Automotive
GPI
$3.97B
$228K ﹤0.01%
3,072
-950
-24% -$74.3K
MNRO icon
1393
Monro
MNRO
$526M
$228K ﹤0.01%
4,372
-1,391
-24% -$78.9K
WABC icon
1394
Westamerica Bancorp
WABC
$1.4B
$227K ﹤0.01%
4,064
-834
-17% -$48K
AKBA icon
1395
Akebia Therapeutics
AKBA
$325M
$226K ﹤0.01%
24,593
-6,499
-21% -$63.4K
NWBI icon
1396
Northwest Bancshares
NWBI
$2.26B
$226K ﹤0.01%
13,430
-4,259
-24% -$74.7K
ZWS icon
1397
Zurn Elkay Water Solutions
ZWS
$8.08B
$226K ﹤0.01%
20,303
-7,879
-28% -$84.9K
IPHI
1398
DELISTED
INPHI CORPORATION
IPHI
$226K ﹤0.01%
4,624
-1,830
-28% -$85.5K
ARGO
1399
DELISTED
Argo Group International Holdings, Ltd.
ARGO
$225K ﹤0.01%
3,817
-1,510
-28% -$86.6K
CSOD
1400
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$225K ﹤0.01%
5,798
-2,291
-28% -$94.4K

Similar funds

ProShare Advisors's Q1 2017 Portfolio in Review

As of Q1 2017, ProShare Advisors held 1,755 positions worth $9.56B, up 5.9% from $9.03B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

ProShare Advisors's Q1 2017 filing shows 15 new, 420 increased, 1,119 reduced and 198 closed positions. Its largest new stake was Qiagen: 113,675 shares worth $3.49M. The largest sale was Healthpeak Properties, an estimated $48.2M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.

  • ProShare Advisors's largest Q1 2017 buy was Qiagen: 113,675 shares worth $3.49M.
  • ProShare Advisors added most to General Dynamics in Q1 2017, an estimated $57.1M increase.
  • ProShare Advisors's biggest Q1 2017 reduction was Healthpeak Properties, cutting an estimated $48.2M.
  • ProShare Advisors fully exited Clarcor in Q1 2017, selling an estimated $15.4M.
  • ProShare Advisors's ten largest holdings make up 14% of its $9.56B portfolio in Q1 2017.
  • ProShare Advisors opened 15 new positions and closed 198 in Q1 2017.
  • ProShare Advisors's portfolio value rose 5.9% quarter-over-quarter to $9.56B.

Based on ProShare Advisors's 13F filing for Q1 2017, filed 25 Apr 2017.